news Novel antiplatelet drug is effective at treating heart attacks in mice, say researchers 16 July 2020 | By Hannah Balfour (Drug Target Review) The novel nanoparticle delivered Mp6 peptide was able to inhibit thrombosis and reduce inflammation without increasing the risk of bleeding in mice after heart attacks.
whitepaper Interview: Stefan Braam, CEO & Founder of Ncardia 16 July 2020 | By Ncardia Mass production with iPSCs: how Ncardia has pushed the boundaries with high-throughput iPSC research.
whitepaper Whitepaper: Neuroinflammation study 15 July 2020 | By Ncardia Neuroinflammation study by combining human iPSC-derived astrocytes and HTRF.
whitepaper Brochure: Particle analysis re-imagined with the Aura™ 13 July 2020 | By Halo Labs Get reproducible and quantitative count, size, morphology and particle ID in one system with the Aura™.
whitepaper Whitepaper: iPSC manufacturing for drug discovery 13 July 2020 | By Ncardia Controlled manufacturing of hiPSC-derived cardiomyocytes in stirred-tank bioreactors enabling high-throughput phenotypic screening.
news Novel vitamin K analogue eliminates seizure activity in epileptic mouse models 7 July 2020 | By Hannah Balfour (Drug Target Review) The vitamin K-based drug has a unique structure which researchers believe makes it effective in controlling even medication-resistant seizures.
news Novel class of non-addictive analgesics demonstrate safety in animals 7 July 2020 | By Hannah Balfour (Drug Target Review) To overcome the issues of current analgesics, researchers reveal a new class of non-narcotic pipeline drugs based on acetaminophen.
news Study identifies eight novel coronavirus replication terminators 6 July 2020 | By Hannah Balfour (Drug Target Review) Scientists reveal eight new molecules, five of which are already US FDA-approved, that can block the polymerase reaction SARS-CoV-2 uses to replicate its genome.
video Video: Ncardia’s iPSC technology 3 July 2020 | By Ncardia This Ncardia company presentation will explain how human stem cell technology offers a solution for drug screening as well as cell therapy projects.
video On-demand webinar: Protein or not? Advanced high throughput aggregate analysis 2 July 2020 | By Halo Labs Protein Or not? Advanced high throughput aggregate analysis with The Aura™ - Find the problem before it happens particle analysis reimagined.
news Experimental formulation could be future for fast-acting insulin 2 July 2020 | By Hannah Balfour (Drug Target Review) The novel formulation hit peak activity at nine minutes, less than half the time taken for a commercially available formulation.
video On-demand webinar: How to be a spectral superstar – NMR & MS analysis made easy 1 July 2020 | By ACD/Labs Software to help synthetic and medicinal chemists process and analyse all their spectral data in a single location.
whitepaper Case study: Better, faster method development at Janssen 30 June 2020 | By ACD/Labs Learn how method development software helped Janssen Pharmaceuticals reduce method development time by 80% with a 25-fold increase in method quality
article Unlocking the power of machine learning for small molecule drug discovery 30 June 2020 | By Victoria Rees (Drug Target Review) Rick Wagner of ZebiAI and Patrick Riley of Google Accelerated Science (GAS) discuss the development and benefits of a new machine learning drug discovery platform.
news Four compounds discovered in starfish show efficacy against cancer cells 29 June 2020 | By Victoria Rees (Drug Target Review) Scientists have revealed that four molecules found in the Ceramaster patagonicus starfish show potency against cancer in cell lines.
